Priority for pSivida's Iluvien; Patent, job, Tweet, and Video of the week;
> The FDA has granted priority review status for Iluvien, a sustained drug delivery system to treat diabetic macular edema. Iluvien was designed by Watertown, MA-based pSivida and licensed to Alimera Sciences based in Alpharetta, GA. Report
> The Institute of Nanotechnology and Cranfield University in the United Kingdom will present a one-day short course, "Nanotechnology for drug delivery," in association with Pharmidex, on Sept. 30. Event
> Using carbon nanotubes to delivery siRNA. Abstract
> Coming attractions from the FDA: New guidance and consensus standards on nanotechnology as part of its 2011 Nanotechnology Regulatory Science Initiative. Bulletin
> A transdermal patch for delivery of contraceptives is among the offerings in India's first patent tech auction. Report
Drug delivery patent of the week: Targeted drug delivery of pain and addiction therapies using opioid receptor-mediated internalization. Patent
Drug delivery job of the week: Dry Powder Inhaler Formulator--3M Drug Delivery Systems Division, Maplewood, MN. Listing
Drug delivery Tweet of the week: @juhayy I think I died a little inside after a short lecture on intraocular way of drug delivery. Five ways of sticking a needle in the eyeball: oh my. Tweet
And Finally... CNN discovers the flu patch. Video
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: